The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III--IV BRAF-Mutated Melanoma Patients Treated With Targeted Therapy--What Can Be Learned From Progression?

Bibliographic Details
Title: The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III--IV BRAF-Mutated Melanoma Patients Treated With Targeted Therapy--What Can Be Learned From Progression?
Authors: van der Hiel, Bernies, Aalbersberg, Else A., den Eertwegh, Alfons J. M. van, de Wit-van der Veen, Linda J., Stokkel, Marcel P. M., Lopez-Yurda, Marta
Source: Clinical Nuclear Medicine; Feb2024, Vol. 49 Issue 2, p138-145, 8p
Database: Complementary Index
More Details
ISSN:03639762
DOI:10.1097/RLU.0000000000004988
Published in:Clinical Nuclear Medicine
Language:English